Orphan drugs and rare diseases: A scientometric review (2000–2014)
Introduction: The literature of orphan drugs and rare diseases between 2000 and 2014 is
reviewed. The overall structure of its intellectual landscape is characterized in terms of …
reviewed. The overall structure of its intellectual landscape is characterized in terms of …
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Hypoxia, characterized by reduced oxygen concentration, is a significant stressor that affects
the survival of aerobic species and plays a prominent role in cardiovascular diseases. From …
the survival of aerobic species and plays a prominent role in cardiovascular diseases. From …
Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery …
SL Chen, FF Zhang, J Xu, DJ Xie, L Zhou… - Journal of the American …, 2013 - jacc.org
Objectives: This study was designed to test the safety and efficacy of pulmonary artery (PA)
denervation (PADN) for patients with idiopathic PA hypertension (IPAH) not responding …
denervation (PADN) for patients with idiopathic PA hypertension (IPAH) not responding …
Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results …
SL Chen, H Zhang, DJ Xie, J Zhang… - Circulation …, 2015 - Am Heart Assoc
Background—The mechanisms underlying pulmonary arterial hypertension (PAH) are
multifactorial. The efficacy of pulmonary artery denervation (PADN) for idiopathic PAH …
multifactorial. The efficacy of pulmonary artery denervation (PADN) for idiopathic PAH …
Molecular mechanisms of pulmonary arterial remodeling
P Crosswhite, Z Sun - Molecular medicine, 2014 - Springer
Pulmonary arterial hypertension (PAH) is characterized by a persistent elevation of
pulmonary arterial pressure and pulmonary arterial remodeling with unknown etiology …
pulmonary arterial pressure and pulmonary arterial remodeling with unknown etiology …
Inorganic nitrite therapy: historical perspective and future directions
Over the past several years, investigators studying nitric oxide (NO) biology and metabolism
have come to learn that the one-electron oxidation product of NO, nitrite anion, serves as a …
have come to learn that the one-electron oxidation product of NO, nitrite anion, serves as a …
Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation
H Zhang, Y Liu, L Yan, S Wang, M Zhang… - Cardiovascular …, 2019 - academic.oup.com
Abstract Aims Long noncoding RNAs (lncRNAs) are involved in the regulation of vascular
smooth muscle cells and cardiovascular pathology. However, the contribution of lncRNAs to …
smooth muscle cells and cardiovascular pathology. However, the contribution of lncRNAs to …
Deletion of the distal C terminus of CaV1. 2 channels leads to loss of β-adrenergic regulation and heart failure in vivo
Y Fu, RE Westenbroek, HY Frank, JP Clark… - Journal of Biological …, 2011 - ASBMB
L-type calcium currents conducted by Ca V 1.2 channels initiate excitation-contraction
coupling in cardiac and vascular smooth muscle. In the heart, the distal portion of the C …
coupling in cardiac and vascular smooth muscle. In the heart, the distal portion of the C …
Long noncoding RNA-maternally expressed gene 3 contributes to hypoxic pulmonary hypertension
Y Xing, X Zheng, Y Fu, J Qi, M Li, M Ma, S Wang, S Li… - Molecular Therapy, 2019 - cell.com
The expression and function of long noncoding RNAs (lncRNAs) in the development of
hypoxic pulmonary hypertension (HPH), especially in the proliferation of pulmonary artery …
hypoxic pulmonary hypertension (HPH), especially in the proliferation of pulmonary artery …
Pharmacologic management of myxomatous mitral valve disease in dogs
CE Atkins, J Häggström - Journal of Veterinary Cardiology, 2012 - Elsevier
Myxomatous mitral valve disease (MMVD) causing mitral regurgitation is the most important
disease of the heart in small animal cardiovascular medicine. Because MMVD is an …
disease of the heart in small animal cardiovascular medicine. Because MMVD is an …